Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital
About this trial
The papers propose a new method to prevent postoperative cerebrospinal fluid leakage. Doctors use the absorbable polyglycolic acid (PGA) and fibrin glue to repair in surgery, prevent cerebrospinal fluid leakage and reduce the necessity of postoperative lumbar drainage after surgery. This study will analyze the changes in cerebrospinal fluid leakage in patients with pituitary tumors and skull base tumors after surgery, and further understand the effectiveness of Neoveil , as the basis for the development of new treatments.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with pituitary gland tumors who do not receive surgical treatment.
Patients with other brain tumors.
Patients allergic to polyglycolic acid (PGA).
Patients who have had previous radiation therapy or chemotherapy.
Trial design
Treatments tested in this trial
- polyglycolic acid(Neoveil)
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov